Tuesday, October 7th
Search EmpowHer  
     

Keyword search

Armed with a lifetime of experiences, women are drawn to the doorway from which the light shines to SHARE with women in need.

To share your own story, simply click on this button:

From this page you can share Study Likely Spells End For Anti-Bleeding Drug to a social bookmarking site or email a link to the page.
Social WebE-mail
Enter multiple addresses on separate lines or separate them with commas.
Study Likely Spells End For Anti-Bleeding Drug
(Your Name) has forwarded a page to you from EmpowHer
(Your Name) thought you would like to see this page from the EmpowHer web site.
     
hernews's picture

Study Likely Spells End For Anti-Bleeding Drug

by hernews
Posted: Thu., May 15, 2008, 07:34 am
55
vote
     
Topics: Blood Clots , Canadian study, Causes, Definition, Medication, Trasylol, News
     

An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs.

Bayer AG, the maker of the drug Trasylol, said it is still deciding what to do and is awaiting details from the Canadian study. Bayer faces dozens of lawsuits claiming Trasylol led to excess deaths and that the company hid evidence of harm.

Read full story
     
     
     
Login or Join Now to Ask and Share


ADVERTISEMENT

Join Our FREE Mailing List

EmpowHer Feeds

Syndicate content